Executive Director, Global Development Lead - Next Generation (Immunology & Cardiovascular)

Bristol Myers Squibb • Cambridge Crossing, MA

66d • $340,870 - $413,051 • Hybrid

About The Position

Global Program Leads within the ICV Global Program Leadership organization are strategic-thinking, problem-solving, and action oriented scientific leaders who bring drug development and commercialization insights to drive a sustainable pipeline of innovative medicines. GPLs serve as the 'point of accountability' for their assets and are respected, matrix leaders, overseeing multi-disciplinary teams typically responsible for the development of assets from later stage Discovery (pre-GT2) through commercialization. They will foster a high performing, highly collaborative, truth-seeking team environment aimed at developing and implementing compelling, integrated asset strategies to achieve ambitious near- and long-term portfolio objectives. Each leader is accountable to therapeutic area, R&D, commercial and Company Leadership for: (i) creating a vision and defining the strategy and integrated development plan for each asset within their portfolio, (ii) developing a set of objective criteria against which each asset advancing through the pipeline will be evaluated to enable robust debate and rapid, data-driven decision making; and (iii) ensuring that only high quality and differentiated assets enter the market.

Requirements

• MD, PhD, DVM, PharmD, MBA or equivalent advanced degree of relevance, with experience in the drug development process.
• 10+ years of experience in the drug development process and leadership experience in academic or industry setting.
• Expertise in the drug development process with in-depth know how and experience in matrix team leadership.
• Successful track record of leading through influence and working across complex, global organizational matrix.
• Significant experience in immunology preferred, with demonstrated understanding of the role of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology.
• Strong understanding of relevant regulatory health authority expectations and regulations for drug development.
• Working knowledge of all functional areas of exploratory development.
• Demonstrated scientific acumen and mechanistic understanding of pharmacology and disease biology.
• Ability to create a clear purpose, global vision, strategies and key priorities for competing successfully in the evolving pharmaceutical and health care industry.
• Demonstrated ability to lead cross-functional team to execute Development Plans.
• Demonstrated ability to objectively assess complex but relatively sparse data sets.
• Demonstrated ability to present complex programs to senior leaders and influence decision making.
• Experience in successfully managing and leading high performing, cross-functional matrix teams.
• Demonstrated ability to coach and mentor others to enhance performance.
• Ability to effectively and seamlessly multi-task, and prioritize across multiple development assets.
• Demonstrated ability to successfully and effectively cooperate, collaborate and work across functions.
• Demonstrated ability to advise and participate in business development due-diligence evaluations.

Responsibilities

• Uses an understanding of disease biology, the drug development process (particularly cross-functional connectivity), and relevant late-stage challenges to create a vision for each asset, then design and execute effective development programs in support of the overall R&D portfolio goals.
• Effectively engages cross company expertise and utilizes advisory groups and governance bodies to define, revise and champion asset development strategies and implementation plans.
• Continually analyzes progress, engages in critical thinking, and asserts strong problem-solving toward delivering key data and interpretation essential for robust debate and rapid, data-driven decision making on assigned projects.
• Delivers high quality assets to commercial which have the potential for a competitive profile to address the unmet medical needs of patients and to provide favorable shareholder return.
• Ensures the process and output of the team meets established program standards while also looking for opportunities to streamline development and enable continuous improvements without compromising quality.
• Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans with functional area capabilities, and clearly communicates program risks, implications of changes in the competitive landscape and progress toward key milestones.
• Actively provides input to and drives portfolio level strategy for both internal and external opportunities.
• Participates in regulatory filings (NDA, BLA filings) as well as develops strategy for orphan drug designation.
• Engages with Health Authorities and/or Advisory Committees in the design of clinical trials and endpoints.
• Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design.
• Builds and maintains collaborative relationships with external stakeholders and appropriately incorporates insights and advice to maximize program impact.
• Understands clinical trial operational complexities from study start up through enrollment, quality assurance, and study readout.
• Has an active role in analysis and/or interpretation of clinical data and translation into scientific communication strategy, including publications, and commercial strategy.
• Understands and reflects the impact of VAP inputs in clinical trial design.
• Actively supports Investor Relations and Public Affairs in managing external BMS communications.
• Integrates commercialization inputs and deliverables to design the late program strategy that enables approval of a meaningfully differentiated asset with potential to maximize asset value.
• Understands necessary commercial inputs needed to inform the end-to-end development process leading to regulatory approval and successful commercialization.
• Integrates market inputs into the integrated development plan, including clinical plans and labeling strategy.
• Understands and contributes to development of forecasts and investment scenarios, how to assess risk and conduct valuations, and implications for decision-making.
• Contributes to the development of brand hallmarks and brand strategy.
• In partnership with Medical Affairs, supports development of KOL plans and engagements.
• Supports commercial needs and recommendations to guide CMC and GPS on trade packaging and commercial product.

Benefits

• Medical, pharmacy, dental and vision care.
• Wellbeing support such as the BMS Living Life Better program and employee assistance programs (EAP).
• Financial well-being resources and a 401(K).
• Financial protection benefits such as short- and long-term disability, life insurance, supplemental health insurance.
• Work-life programs including paid national holidays and optional holidays.
• Global Shutdown Days between Christmas and New Year's holiday.
• Up to 120 hours of paid vacation.
• Up to two (2) paid days to volunteer.
• Sick time off and summer hours flexibility.
• Parental, caregiver, bereavement, and military leave.
• Family care services such as adoption and surrogacy reimbursement, fertility/infertility benefits.
• Other perks like tuition reimbursement and a recognition program.

What This Job Offers

• Job Type: Full-time
• Career Level: Senior
• Industry: Chemical Manufacturing
• Education Level: Ph.D. or professional degree
• Number of Employees: 5,001-10,000 employees